Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Nuclear Medicine

• Publication date

  1996-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 8683310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.

  1996cited by this paper
• Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.

  1994cited by this paper
• Somatostatin-Receptor Imaging of Medullary Thyroid Carcinoma

  1994influential reference
• The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid.

  1994influential reference
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

  1993cited by this paper
• In vivo somatostatin receptor imaging in medullary thyroid carcinoma.

  1993cited by this paper
• Results of long‐term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma

  1992cited by this paper
• In vitro and in vivo detection of somatostatin receptors in human malignant tissues.

  1991cited by this paper
• Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.

  1991cited by this paper
• The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

  1991cited by this paper
• Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.

  1989cited by this paper
• Surgery of C Cell Carcinoma of the Thyroid

  1988cited by this paper
• Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies.

  1988cited by this paper
• Radioiodinated meta‐iodobenzylguanidine uptake in medullary thyroid cancer: A French cooperative study

  1987cited by this paper
• Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy.

  1986cited by this paper
• 99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma

  1986cited by this paper
• Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.

  1982cited by this paper

• Medullary Thyroid Carcinoma: Imaging.

  2025cites this paper
• Medullary Thyroid Cancer

  2022cites this paper
• Functional imaging in thyroid cancer patients with metastases and therapeutic implications.

  2022cites this paper
• Systemic treatment of advanced, metastatic, medullary thyroid carcinoma

  2021cites this paper
• Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives

  2021cites this paper
• EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma

  2019cites this paper
• ACR Appropriateness Criteria® Thyroid Disease.

  2019cites this paper
• Thyroid disease

  2018cites this paper
• Thyroid disease

  2018cites this paper
• Refractory thyroid carcinoma: which systemic treatment to use?

  2018cites this paper
• Medullary Thyroid Cancer: Diagnosis and Non Surgical Management

  2018cites this paper
• Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

  2018cites this paper
• 68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging

  2017cites this paper
• Radionuclide Imaging of Medullary Thyroid Carcinoma

  2017cites this paper
• The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values

  2017cites this paper
• Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma

  2016cites this paper
• 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.

  2016cites this paper
• A Comparison of the ATA, NCCN, ETA, and BTA Guidelines for the Management of Medullary Thyroid Cancer

  2016cites this paper
• Radionuclide Therapy of Thyroid Tumors

  2016cites this paper
• American Thyroid Association guidelines for the management of medullary thyroid carcinoma

  2015cites this paper
• PET imaging with 68gallium labelled somatostatin analogues in the evaluation of neuroendocrine tumours (NETs)

  2015cites this paper
• Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

  2015cites this paper
• Somatostatin Receptor Scintigraphy in Medullary Thyroid Cancer

  2015cites this paper
• Medullary Thyroid Carcinoma: Imaging.

  2015cites this paper
• Diagnostic imaging of medullary thyroid cancer

  2015cites this paper
• Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.

  2015cites this paper
• PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: An overview and single institutional experience from India

  2014cites this paper
• Update on medullary thyroid cancer.

  2014cites this paper
• Calcitonin stimulation tests for the early diagnosis and follow-up of patients with C cell disease: a descriptive analysis.

  2013cites this paper
• Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with 18F-FDG-PET and MIBI images

  2013cites this paper
• Routine preoperative 111In-octreotide scintigraphy in patients with medullary thyroid cancer

  2013cites this paper
• Thyroid and Parathyroid Tumors

  2013cites this paper
• Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE Octreotide Scintigraphy With FDG PET and 99mTc-MIBI in Local Recurrent or Distant Metastatic Thyroid Cancers

  2013cites this paper
• (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.

  2012cites this paper
• Somatostatin receptor SPECT

  2012cites this paper
• Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

  2012cites this paper
• Treatment of Progressive Dedifferentiated and Medullary Thyroid Cancer with Radiolabeled Somatostatin Analogs

  2012cites this paper
• Genetic and molecular pathophysiology of medullary thyroid cancer.

  2011cites this paper
• Diagnosis of Multiple Endocrine Neoplasia Type 2A in Patients With Positive Thyroid Imaging by Iodine-131 Metaiodobenzylguanidine Scintigraphy

  2011cites this paper
• Detektion okkulter medullärer Schilddrüsenkarzinome bei Patienten einer universitären Schilddrüsen-Ambulanz: Diagnostischer Wert von Calcitonin-Screening, Pentagastrintest und Gastrinrezeptorszintigraphie

  2010cites this paper
• Molecular imaging in thyroid cancer

  2010cites this paper
• Medullary thyroid carcinoma.

  2010cites this paper
• Artigo de Revisão Taking decisions in thyroid medullary carcinoma

  2009cites this paper
• Toma de decisiones en carcinoma medular de tiroides

  2009cites this paper
• Medullary thyroid carcinoma and biomarkers: past, present and future

  2009cites this paper
• Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

  2009cites this paper
• Thyroid disease

  2009cites this paper
• Somatostatin Analogue Therapy

  2008cites this paper
• Radiodétection peropératoire des tumeurs endocrines

  2008cites this paper
• Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.

  2008cites this paper
• MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?

  2008cites this paper
• New therapeutic approaches to treat medullary thyroid carcinoma

  2008cites this paper
• Radioguided Surgery of Neuroendocrine Tumors

  2008cites this paper
• In vivo fluorescence of medullary carcinoma of the thyroid: a technology with potential to improve visualization of malignant tissue at surgical resection.

  2008cites this paper
• Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

  2008cites this paper
• Thyroid Cancer: 18F-FDG-Positron Emission Tomography

  2008cites this paper
• Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma

  2007cites this paper
• Gallium-68 PET: a new frontier in receptor cancer imaging.

  2007cites this paper
• PET Application in Neuroendocrine Tumors

  2007cites this paper
• Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

  2007cites this paper
• The Evolving Role of Positron Emission Tomography in Patients with Medullary Thyroid Carcinoma.

  2007cites this paper
• Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery

  2007cites this paper
• Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Detecting Unknown Cause of Elevation of Carcinoembryonic Antigen (CEA) in Occult Medullary Thyroid Cancer

  2007cites this paper
• Radionuclide Imaging of Medullary Carcinoma

  2006cites this paper
• Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.

  2006cites this paper
• Practical Management Of Thyroid Cancer

  2006cites this paper
• External Radiation Therapy of Papillary Cancer

  2006cites this paper
• Medullary Thyroid Cancer: Diagnosis and Management

  2006cites this paper
• Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours

  2006cites this paper
• Imaging of neuroendocrine tumors.

  2006cites this paper
• Medullary thyroid cancer: Medical management and follow-up

  2005cites this paper
• The present and future role of (111)In pentetreotide in the PET era.

  2005cites this paper
• Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients.

  2005cites this paper
• Medullary thyroid carcinoma

  2004cites this paper
• Octreotide Scintigraphy in the Head and Neck

  2004cites this paper
• The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy

  2004cites this paper
• Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.

  2004cites this paper
• Medullary thyroid carcinoma

  2004influential citation
• Somatostatin Receptor Imaging In Recurrent Medullary Thyroid Cancer

  2004cites this paper
• Receptor-Mediated Tumor Targeting with Radiopeptides. Part 1. General Concepts and Methods: Applications to Somatostatin Receptor-Expressing Tumors

  2004cites this paper
• 99mTc-EDDA/HYNIC-TOC in the Management of Medullary Thyroid Carcinoma

  2004cites this paper
• The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.

  2004cites this paper
• Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner.

  2003cites this paper
• Medullary thyroid carcinoma and hormones.

  2003cites this paper
• Thyroid disease.

  2003cites this paper
• 111In‐labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours

  2003cites this paper
• La gammagrafía de receptores de somatostatina en los tumores neuroendocrinos

  2002cites this paper
• Indium-111-octreotide Scintigraphy, Intraoperative Gamma-detector Localisation and Somatostatin Receptor Expression in Primary Human Breast Cancer

  2002cites this paper
• La gammagrafía de receptores de somatostatina en los tumores neuroendocrinos

  2002cites this paper
• 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.

  2002cites this paper
• Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma

  2001cites this paper
• Octreotide for Cancer of the Liver and Biliary Tree

  2001cites this paper
• Radioisotope‐guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma

  2001cites this paper
• A Large Family with Hereditary MTC: Role of RET Genetic Analysis in Differential Diagnosis Between MEN 2A and FMTC

  2001cites this paper
• A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.

  2001cites this paper
• Cancer médullaire de la thyroïde

  2001cites this paper
• Nuclear medicine imaging of neuroendocrine tumours.

  2001cites this paper
• Diagnostik und Therapie des Schilddrüsenkarzinoms

  2001cites this paper
• Treatment of medullary thyroid carcinoma: an update.

  2001cites this paper
• and Somatostatin Receptor Subtypes in Thyroid Tumors

  2000cites this paper